Related Experiment Video
Updated: Jul 4, 2025
11:06
Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
2.0K
Guggulsterone - a potent bioactive phytosteroid: synthesis, structural modification, and its improved bioactivities.
T P Adarsh Krishna1, T P Ajeesh Krishna2,3, Baldev Edachery1
1R & D Division, Sreedhareeyam Farmherbs India Pvt. Ltd Kerala 686 662 India adarshkrishnatp@gmail.com.
RSC Medicinal Chemistry
|January 29, 2024
Summary
Guggulsterone, a plant-derived steroid, is synthesized through various routes and modified to enhance its medicinal properties. This review highlights green chemistry approaches for guggulsterone synthesis and its derivatives.
Area of Science:
- Phytochemistry
- Organic Chemistry
- Medicinal Chemistry
Background:
- Guggulsterone is a phytosteroid from *Commiphora wightii*, a critically endangered plant.
- It possesses significant biochemical potential and has undergone clinical evaluation.
- Limited natural abundance necessitates synthetic and modified approaches for its therapeutic applications.
Purpose of the Study:
- To review advancements in the chemical synthesis of guggulsterone.
- To explore structural modifications aimed at improving guggulsterone's biological activities.
- To emphasize the application of green chemistry principles in guggulsterone research.
Main Methods:
- Literature review of synthetic routes for guggulsterone.
- Analysis of structure-activity relationship studies for guggulsterone derivatives.
- Focus on sustainable and green chemistry methodologies in steroid synthesis.
Main Results:
- Development of diverse synthetic pathways for guggulsterone from steroid precursors.
- Identification of structural modifications that enhance biological properties.
- Integration of green chemistry principles into synthetic strategies.
Conclusions:
- Green chemistry offers sustainable routes for guggulsterone production.
- Structural modifications can significantly improve the therapeutic efficacy of guggulsterone derivatives.
- This review provides a valuable resource for researchers in steroid chemistry and guggulsterone development.
More Related Videos
Related Concept Videos
01:14Drug Metabolism: Phase II Reactions
3.8K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
3.8K
01:16Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.0K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.0K
01:16Drug Biotransformation: Overview
2.4K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.4K
01:30Prodrugs
2.6K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.6K
01:09GPCRs Regulate Adenylyl Cylase Activity
5.6K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.6K
01:24Phase II Reactions: Glucuronidation
428
Glucuronidation, a pivotal phase II biotransformation process, involves the coupling of glucuronic acid to a drug or xenobiotic. Given its widespread occurrence and critical role in drug metabolism, it's considered the most crucial phase II reaction. It enhances the water solubility of substances, aiding their expulsion from the body. The driving force behind these reactions is a group of enzymes known as UDP-glucuronosyltransferases (UGTs). UGTs facilitate the transfer of a glucuronic acid...
428